Hudson Bay Capital Management LP Medicenna Therapeutics Corp. Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.44 - $0.82 $19,132 - $35,656	-43,483 Reduced 5.28%	780,564 $374,000
Q1 2023 May 15, 2023	SELL	$0.5 - $0.78 $55,150 - $86,034	-110,300 Reduced 11.81%	824,047 $519,000
Q4 2022 Feb 14, 2023	SELL	$0.4 - $0.68 $26,261 - $44,644	-65,653 Reduced 6.57%	934,347 $429,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $1.78 $830,000 - $1.78 Million	1,000,000 New	1,000,000 $830,000

863K

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.